 | Up a level |
Lucas, M. G.; Bosch, R. J. L.; Burkhard, F. C.; Cruz, F.; Madden, T. B.; Nambiar, A. K.; Neisius, A.; de Ridder, D. J. M. K.; Tubaro, A.; Turner, W. H.; Pickard, R. S. (2013). EAU guidelines on surgical treatment of urinary incontinence. Actas urológicas españolas, 37(8), pp. 459-472. Elsevier Doyma 10.1016/j.acuro.2013.02.002
Burkhard, F. C.; Markwalder, R.; Thalmann, G. N.; Studer, U. E. (1997). Immunohistochemical determination of p53 overexpression. Urological research, 25(S1), S31-S35. Springer-Verlag 10.1007/BF00942045
Küffer, M.; Besic, M.; Hashemi Gheinani, A.; Vassella, E.; Schneider, M.; Burkhard, F. C.; Monastyrskaya, K. (15 March 2019). Urinary miRNA profiles discriminate between BPO patients and healthy controls. European Urology Supplements, 18(1), e715-e715. Elsevier 10.1016/S1569-9056(19)30525-1
Monastyrskaya, K.; Besic, M.; Hashemi Gheinani, A.; Burkhard, F. C. (15 March 2019). Dysregulation of phospholamban and beta 3-adrenergic receptor expression might lead to bladder detrusor overactivity via SERCA inhibition. European Urology Supplements, 18(1), e711-e711. Elsevier 10.1016/S1569-9056(19)30521-4
